FGI-103

CAS No. 907169-69-1

FGI-103( FGI103 )

Catalog No. M16519 CAS No. 907169-69-1

FGI-103 is a small-molecule inhibitor of filovirus that exhibits potent antiviral activity against of EBOV and MARV.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    FGI-103
  • Note
    Research use only, not for human use.
  • Brief Description
    FGI-103 is a small-molecule inhibitor of filovirus that exhibits potent antiviral activity against of EBOV and MARV.
  • Description
    FGI-103 is a small-molecule inhibitor of filovirus that exhibits potent antiviral activity against of EBOV (EC90=330 nM, ZEBOV) and MARV (EC50=2.5 uM, MARV-Ci67); protects mice against a lethal challenge with a mouse-adapted strain of either ZEBOV or MARV-Ravn as a single intraperitoneal dose of 10 mg/kg; reduces viremia and the viral burden in kidney, liver, and spleen tissues in a murine model of ZEBOV infection.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    FGI103
  • Pathway
    Microbiology/Virology
  • Target
    Filovirus
  • Recptor
    Filovirus
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    907169-69-1
  • Formula Weight
    344.369
  • Molecular Formula
    C19H16N6O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1=CC2=C(C=C1C(=N)N)NC(=N2)C=CC3=CC4=C(O3)C=CC(=C4)C(=N)N
  • Chemical Name
    2-[(E)-2-(5-Carbamimidoyl-1-benzofuran-2-yl)vinyl]-1H-benzimidazol-6-carboximidamid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Warren TK, et al. Antimicrob Agents Chemother. 2010 May;54(5):2152-9. 2. Haque A, et al. Antimicrob Agents Chemother. 2015 Oct;59(10):5892-902. 3. De Clercq E. Med Res Rev. 2013 Nov;33(6):1249-77.
molnova catalog
related products
  • MK-0608

    A nucleoside analogue that shows potent inhibition for replication of several mosquito-borne flaviviruses including DENV and ZIKV.

  • FGI-106

    FGI-106 is a broad-spectrum inhibitor of multiple blood-borne viruses (HCV, HBV, HIV) as well as emerging biothreats.

  • IHVR-19029

    IHVR-19029 is a novel antiviral compound that acts as ER α-glucosidase inhibitor.